Feedback / Questions
LiProSal (lithium/proline/salicylate) - Alzamend Neuro
https://www.businesswire.com/news/home/20220517005595/en/Alzamend-Neuro-Announces-Pre-IND-Submission-for-AL001-as-a-Treatment-of-Bipolar-Disorder-Major-Depressive-Disorder-and-Post-Traumatic-Stress-Disorder
May 17, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next